Determination of stage specific markers for liver fibrosis in hepatitis B: A comparative tissue proteomic study

Basit Öğe Kaydı
dc.contributor.authorKatrinli, Şeyma
dc.contributor.authorÖzdil, Kamil
dc.contributor.authorŞahin, Aslı
dc.contributor.authorÖztürk, Oğuzhan
dc.contributor.authorKır, Gözde
dc.contributor.authorBaykal, Ahmet Tarık
dc.contributor.authorSaraç, Ömer Sinan
dc.contributor.authorSökmen, Mehmet
dc.contributor.authorDinler Doğanay, Gizem
dc.contributor.authorDoğanay, Hamdi Levent
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:58:15Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:58:15Z
dc.date.issued2016
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalı
dc.descriptionEASL International Liver Congress -- APR 13-17, 2016 -- Barcelona, SPAIN
dc.descriptionWOS: 000398711700732
dc.description.abstractBackground and Aims: Chronic Hepatitis B infection is one of themajor causes of liver cirrhosis and around 600,000 people dieannually worldwide. The virus itself is non-cytopathic and the liverdamage is due to host immune reaction. Thus liver damage pathwaysmight differ in chronic HBV and comprehensive tissue proteomicanalysis is missing in literature. To estimate which patient withchronic hepatitis B will develop rapidly fibrosis or cirrhosis is yet athorny issue and requires a vast recognition of cellular pathwaysinvolved in fibrosis. The aim of this study is to enlighten pathwaysassociated with liver fibrosis in HBV infection for leading up to newtherapeutic targets and diagnostic biomarkers.
dc.description.sponsorshipEASLen_US
dc.identifier.citationKatrinli, Ş., Özdil, K., Şahin, A., Öztürk, O., Kır, G., Baykal, A. T. ... Doğanay, H. L. (2016). Determination of stage specific markers for liver fibrosis in hepatitis B: A comparative tissue proteomic study. EASL International Liver Congress içinde (S446-S446. ss.). Barcelona, Spain, April 13-17, 2016. https://dx.doi.org/10.1016/S0168-8278(16)00738-8
dc.identifier.doi10.1016/S0168-8278(16)00738-8
dc.identifier.endpageS446
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.issueSupplement: 2
dc.identifier.startpageS446
dc.identifier.urihttps://dx.doi.org/10.1016/S0168-8278(16)00738-8
dc.identifier.urihttps://hdl.handle.net/20.500.12511/3135
dc.identifier.volume64
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Science B.V.
dc.relation.ispartofEASL International Liver Congressen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHepatitis B
dc.subjectLiver Fibrosis
dc.subjectSpecific Markers
dc.titleDetermination of stage specific markers for liver fibrosis in hepatitis B: A comparative tissue proteomic study
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Baykal, Ahmet Tarık-2016.pdf
Boyut:
64.77 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Bildiri Koleksiyonu